{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:45:57Z","timestamp":1789058757252,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.lfs.2020.117429","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:07:30Z","timestamp":1581538050000},"page":"117429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clopidogrel or prasugrel reduces mortality and lessens cardiovascular damage from acute myocardial infarction in hypercholesterolemic male rats"],"prefix":"10.1016","volume":"247","author":[{"given":"Hala M.F.","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Makary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Atef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Sherbiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebatallah H.","family":"Atteia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehan A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelaty Shawky","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan A.","family":"Zaitone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.117429_bb0005","doi-asserted-by":"crossref","first-page":"697-697","DOI":"10.1002\/emmm.201100182","article-title":"Cardiovascular disease review series","volume":"3","author":"Dimmeler","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.lfs.2020.117429_bb0010","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1038\/cddis.2011.130","article-title":"Cardiomyocyte death: mechanisms and translational implications","volume":"2","author":"Chiong","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.117429_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jjcc.2011.03.006","article-title":"Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage","volume":"58","author":"Kume","year":"2011","journal-title":"J. Cardiol."},{"key":"10.1016\/j.lfs.2020.117429_bb0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.thromres.2004.07.020","article-title":"Platelet physiology and thrombosis","volume":"114","author":"Andrews","year":"2004","journal-title":"Thromb. Res."},{"key":"10.1016\/j.lfs.2020.117429_bb0025","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.103.13.1718","article-title":"Inflammation and thrombosis: the clot thickens","volume":"103","author":"Libby","year":"2001","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2020.117429_bb0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/01.CIR.93.2.229","article-title":"Platelet function in acute myocardial infarction treated with direct angioplasty","volume":"93","author":"Gawaz","year":"1996","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2020.117429_bb0035","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1540-8183.2008.00408.x","article-title":"The rationale for and comparisons of different antiplatelet treatments in acute coronary syndrome","volume":"21","author":"Gurbel","year":"2008","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.lfs.2020.117429_bb0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0034-1365839","article-title":"The influence of diet and nutrients on platelet function","volume":"40","author":"McEwen","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.lfs.2020.117429_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1139\/Y08-011","volume":"86","author":"Prociuk","year":"2008","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0050","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"Roe","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117429_bb0055","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/j.1538-7836.2006.02192.x","article-title":"Nucleotide receptor signaling in platelets","volume":"4","author":"Kahner","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.lfs.2020.117429_bb0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH07-11-0673","article-title":"P2 receptors, platelet function and pharmacological implications","volume":"99","author":"Gachet","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.lfs.2020.117429_bb0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-2005-869524","article-title":"Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y 12 receptor antagonist activity","volume":"31","author":"Niitsu","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.lfs.2020.117429_bb0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1527-3466.2007.00027.x","article-title":"Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile: PRASUGREL","volume":"25","author":"Jakubowski","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.lfs.2020.117429_bb0075","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1160\/TH11-12-0867","article-title":"Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse","volume":"107","author":"Totani","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.lfs.2020.117429_bb0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/FJC.0b013e3182244a6f","article-title":"Selective blockade of P2Y12 receptors by prasugrel inhibits myocardial infarction induced by thrombotic coronary artery occlusion in rats","volume":"58","author":"Sugidachi","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/15376516.2014.972531","article-title":"Benidipine prevents oxidative stress, inflammatory changes and apoptosis related myofibril damage in isoproterenol-induced myocardial infarction in rats","volume":"25","author":"Hassan","year":"2015","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.lfs.2020.117429_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3923\/jpt.2011.1.17","article-title":"Isoproterenol induced myocardial infarction: protective role of natural products","volume":"6","author":"Upaganlawa","year":"2011","journal-title":"J. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2020.117429_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.intimp.2017.05.002","article-title":"Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-\u03baB and JAK\/STAT signaling pathways in rats","volume":"48","author":"Zhao","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-079X.2006.00346.x","article-title":"Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats","volume":"41","author":"Pan","year":"2006","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.117429_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/SHK.0b013e3181f48987","article-title":"Adenosine diphosphate receptor antagonist clopidogrel sulfate attenuates LPS-induced systemic inflammation in a rat model","volume":"35","author":"Hagiwara","year":"2011","journal-title":"Shock."},{"key":"10.1016\/j.lfs.2020.117429_bb0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cca.2003.10.011","article-title":"Chronic oral administration of raw garlic protects against isoproterenol-induced myocardial necrosis in rat","volume":"136","author":"Banerjee","year":"2003","journal-title":"Comp. Biochem. Physiol. Part C Toxicol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1139\/cjpp-2015-0135","article-title":"Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis","volume":"94","author":"Khodeer","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2012.06.022","article-title":"Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF","volume":"691","author":"Zaitone","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2010.05.038","article-title":"Heart rate correction of the QT duration in rats","volume":"641","author":"Kmecova","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tvjl.2007.01.026","article-title":"The effect of physical exercise on the daily rhythm of platelet aggregation and body temperature in horses","volume":"176","author":"Piccione","year":"2008","journal-title":"Vet. J."},{"key":"10.1016\/j.lfs.2020.117429_bb0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0009-8981(85)90091-9","article-title":"Estimation of VLDL cholesterol in hyperlipidemia","volume":"151","author":"Wilson","year":"1985","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2020.117429_bb0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2020.117429_bb0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1139\/cjpp-2017-0252","article-title":"Triiodothyronine attenuates the progression of renal injury in a rat model of chronic kidney disease","volume":"96","author":"El Agaty","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"key":"10.1016\/j.lfs.2020.117429_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00990","article-title":"Pharmacological action of a pregnane glycoside, russelioside B, in dietary obese rats: impact on weight gain and energy expenditure","volume":"9","author":"Abdel-Sattar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2011.04.049","article-title":"Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease","volume":"662","author":"Zaitone","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-4800(89)90002-6","article-title":"Quantitation of oil red O staining of the aorta in hypercholesterolemic rats","volume":"51","author":"Nunnari","year":"1989","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.lfs.2020.117429_bb0170","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/01.ATV.11.1.154","article-title":"Comparison of early microcirculatory and aortic changes in hypercholesterolemic rats","volume":"11","author":"Schuschke","year":"1991","journal-title":"Arterioscler. Thromb. J. Vasc. Biol"},{"key":"10.1016\/j.lfs.2020.117429_bb0175","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1074248418763957","article-title":"Cardioprotective and anti-aggregatory effects of levosimendan on isoproterenol-induced myocardial injury in high-fat-fed rats involves modulation of PI3K\/Akt\/mTOR signaling pathway and inhibition of apoptosis: comparison to cilostazol","volume":"23","author":"Tawfik","year":"2018","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2020.117429_bb0180","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.ATV.19.2.239","article-title":"Low-density lipoprotein enhances platelet secretion via integrin-\u03b1 IIb \u03b23\u2013mediated signaling","volume":"19","author":"Hackeng","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2020.117429_bb0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2362.1994.tb02423.x","article-title":"Platelet function in patients with hypercholesterolaemia","volume":"24","author":"Betteridge","year":"1994","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.lfs.2020.117429_bb0190","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0002-9149(97)00974-0","article-title":"Dyslipidemias have a detrimental effect on left ventricular systolic function in patients with a first acute myocardial infarction","volume":"81","author":"Wang","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2020.117429_bb0195","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1172\/JCI4829","article-title":"Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase","volume":"103","author":"Feron","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.117429_bb0200","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/01.CIR.99.24.3092","article-title":"Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase","volume":"99","author":"Ito","year":"1999","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2020.117429_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bjp.0705098","article-title":"Attenuation of increased myocardial ischaemia-reperfusion injury conferred by hypercholesterolaemia through pharmacological inhibition of the caspase-1 cascade","volume":"138","author":"Wang","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0210","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJM197402212900805","article-title":"Platelet function in hyperlipoproteinemia","volume":"290","author":"Carvalho","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117429_bb0215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0038-1657206","article-title":"Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidemic patients","volume":"48","author":"Strano","year":"1982","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.lfs.2020.117429_bb0220","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0022-2275(20)39797-2","article-title":"Platelet function and platelet lipid composition in the dyslipoproteinemias","volume":"21","author":"Shastri","year":"1980","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2020.117429_bb0225","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0049-3848(76)90199-7","article-title":"Effect of diet-induced hyperlipidemia on in vitro-function of rabbit platelets","volume":"9","author":"Joist","year":"1976","journal-title":"Thromb. Res."},{"key":"10.1016\/j.lfs.2020.117429_bb0230","first-page":"361","article-title":"Effects of diet on blood clotting and platelet aggregation","volume":"67","author":"Renaud","year":"1981","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.lfs.2020.117429_bb0235","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.50.3.570","article-title":"Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia","volume":"50","author":"Carvalho","year":"1974","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2020.117429_bb0240","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1042\/cs0640637","article-title":"Platelet function and lipoprotein levels after plasma-exchange in patients with familial hypercholesterolaemia","volume":"64","author":"Brook","year":"1983","journal-title":"Clin. Sci."},{"key":"10.1016\/j.lfs.2020.117429_bb0245","first-page":"60","article-title":"Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease","volume":"1","author":"Badimon","year":"2012","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.lfs.2020.117429_bb0250","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0300-8932(09)72385-1","article-title":"Lipoproteins, platelets, and atherothrombosis","volume":"62","author":"Badim\u00f3n","year":"2009","journal-title":"Rev. Esp. Cardiol. Engl. Ed."},{"key":"10.1016\/j.lfs.2020.117429_bb0255","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1538-7836.2007.02483.x","article-title":"Plaque progression and regression in atherothrombosis: plague progression and regression in atherothrombosis","volume":"5","author":"Ibanez","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.lfs.2020.117429_bb0260","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2020.117429_bb0265","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s11239-014-1150-x","article-title":"Haemostatic risk factors in dyslipidemic rabbits: role of 10-dehydrogingerdione as a new hypolipemic agent","volume":"39","author":"El-Seweidy","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.lfs.2020.117429_bb0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000051028","article-title":"Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine","volume":"38","author":"Szilv\u00e1ssy","year":"2001","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.lfs.2020.117429_bb0275","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lfs.2007.04.027","article-title":"Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine","volume":"81","author":"Bolayirli","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.117429_bb0280","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0306-3623(00)00074-4","article-title":"Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits","volume":"34","author":"Maeso","year":"2000","journal-title":"Gen. Pharmacol. Vasc. Syst."},{"key":"10.1016\/j.lfs.2020.117429_bb0285","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/157016105774329453","article-title":"Endothelin-1 and human platelets","volume":"3","author":"Jagroop","year":"2005","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0008-6363(97)00212-5","article-title":"Development of heart failure following isoproterenol administration in the rat: role of the renin\u2013angiotensin system","volume":"37","author":"Grimm","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2020.117429_bb0295","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-2952(95)02118-3","article-title":"Effect of curcumin on cetrain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats","volume":"51","author":"Nirmala","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0300","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.biopha.2017.05.049","article-title":"Cardiotoxic effect of levofloxacin and ciprofloxacin in rats with\/without acute myocardial infarction: impact on cardiac rhythm and cardiac expression of Kv4.3, Kv1.2 and Nav1.5 channels","volume":"92","author":"Abdelrady","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2020.117429_bb0305","doi-asserted-by":"crossref","first-page":"H638","DOI":"10.1152\/ajpheart.1995.269.2.H638","article-title":"Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart","volume":"269","author":"Boluyt","year":"1995","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2020.117429_bb0310","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ahj.2015.07.030","article-title":"Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: optimization of antiplatelet treatment in patients 70years and older\u2014rationale and design of the POPular AGE study","volume":"170","author":"Qaderdan","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.lfs.2020.117429_bb0315","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117429_bb0320","first-page":"1395","article-title":"Anatomical study of auditory brainstem implantation through retrosigmoid approach","volume":"89","author":"Cai","year":"2009","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.lfs.2020.117429_bb0325","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.amjcard.2014.02.002","article-title":"Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial)","volume":"113","author":"Brener","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2020.117429_bb0330","doi-asserted-by":"crossref","first-page":"105","DOI":"10.14740\/cr560w","article-title":"Comparison of clopidogrel with prasugrel and ticagrelor in patients with acute coronary syndrome: clinical outcomes from the National Cardiovascular Database ACTION Registry","volume":"8","author":"Khayata","year":"2017","journal-title":"Cardiol. Res."},{"key":"10.1016\/j.lfs.2020.117429_bb0335","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2008.04.002","article-title":"Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention","volume":"51","author":"Antman","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2020.117429_bb0340","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ahj.2009.01.003","article-title":"Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"157","author":"James","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.lfs.2020.117429_bb0345","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117429_bb0350","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejphar.2007.10.005","article-title":"Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species","volume":"579","author":"Niitsu","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2009.03.073","article-title":"Effects of prasugrel, a novel P2Y12 inhibitor, in rat models of cerebral and peripheral artery occlusive diseases","volume":"612","author":"Ogawa","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0360","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/ATVBAHA.110.213702","article-title":"Regulation of functionally active P2Y12 ADP receptors by thrombin in human smooth muscle cells and the presence of P2Y12 in carotid artery lesions","volume":"30","author":"Rauch","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2020.117429_bb0365","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1160\/TH07-01-0010","article-title":"The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: influence of other blood cells, calcium","volume":"98","author":"Frelinger","year":"2007","journal-title":"And Aspirin, Thromb. Haemost."},{"key":"10.1016\/j.lfs.2020.117429_bb0370","first-page":"198","article-title":"43 new generation antiplatelet therapies to prevent preeclampsia","volume":"6","author":"Hannan","year":"2016","journal-title":"Pregnancy Hypertens. Int. J. Womens Cardiovasc. Health."},{"key":"10.1016\/j.lfs.2020.117429_bb0375","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/157016108783331295","article-title":"Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis","volume":"6","author":"Schafer","year":"2008","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117429_bb0380","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2010-01-261206","article-title":"Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis","volume":"116","author":"Lievens","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.lfs.2020.117429_bb0385","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1113\/jphysiol.2011.225417","article-title":"Platelets: a critical link between inflammation and microvascular dysfunction: platelet cross-talk in microvascular inflammation","volume":"590","author":"Stokes","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2020.117429_bb0390","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2010.09.050","article-title":"High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation","volume":"57","author":"Patti","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2020.117429_bb0395","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000347122","article-title":"Ticagrelor improves peripheral arterial function in patients with a previous acute coronary syndrome","volume":"124","author":"Torngren","year":"2013","journal-title":"Cardiology."},{"key":"10.1016\/j.lfs.2020.117429_bb0400","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117429_bb0405","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117429_bb0410","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2017.06.099","article-title":"Prasugrel as opposed to clopidogrel improves endothelial nitric oxide bioavailability and reduces platelet-leukocyte interaction in patients with unstable angina pectoris: a randomized controlled trial","volume":"248","author":"Rudolph","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2020.117429_bb0415","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.lfs.2020.117429_bb0420","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s1145-002-0906-2","article-title":"Increased cardiomyocyte apoptosis following ischemia and reperfusion in diet-induced hypercholesterolemia: relation to Bcl-2 and bax proteins and caspase-3 activity","volume":"37","author":"Wang","year":"2002","journal-title":"Lipids."},{"key":"10.1016\/j.lfs.2020.117429_bb0425","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.96.5.1580","article-title":"The bcl-2 gene product prevents programmed cell death of ventricular myocytes","volume":"96","author":"Kirshenbaum","year":"1997","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2020.117429_bb0430","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.CIR.99.23.3071","article-title":"Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat","volume":"99","author":"Condorelli","year":"1999","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2020.117429_bb0435","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0008-6363(99)00354-5","article-title":"Reperfusion induces myocardial apoptotic cell death","volume":"45","author":"Zhao","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2020.117429_bb0440","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1172\/JCI116491","article-title":"Hypercholesterolemia increases endothelial superoxide anion production","volume":"91","author":"Ohara","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.117429_bb0445","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/01.CIR.89.5.2176","article-title":"Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine","volume":"89","author":"Tsao","year":"1994","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2020.117429_bb0450","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.CIR.99.3.434","article-title":"Amelioration by quinapril of myocardial infarction induced by coronary occlusion\/reperfusion in a rabbit model of atherosclerosis: possible mechanisms","volume":"99","author":"Hoshida","year":"1999","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2020.117429_bb0455","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/01.CIR.76.1.173","article-title":"Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion","volume":"76","author":"Golino","year":"1987","journal-title":"Circulation."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520301764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520301764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:30:22Z","timestamp":1758400222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520301764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":91,"alternative-id":["S0024320520301764"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117429","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clopidogrel or prasugrel reduces mortality and lessens cardiovascular damage from acute myocardial infarction in hypercholesterolemic male rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117429"}}